ATE227572T1 - Lebenschützende mittel, verfahren zu deren verwendung sowie extraktionsverfahren für curcuminoide - Google Patents

Lebenschützende mittel, verfahren zu deren verwendung sowie extraktionsverfahren für curcuminoide

Info

Publication number: ATE227572T1
Authority: AT; Austria
Prior art keywords: cucuminoids; life; protecting agents; curcumin; extraction method
Prior art date: 1995-07-14

Application number

AT96923703T

Other languages

English (en)

Inventor

Muhammed Majeed

Vladimir Badmaev

R Rajendran

Original Assignee

Sabinsa Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-14

Filing date

1996-07-12

Publication date

2002-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21694687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE227572(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-07-12 Application filed by Sabinsa Corp filed Critical Sabinsa Corp

2002-11-15 Application granted granted Critical

2002-11-15 Publication of ATE227572T1 publication Critical patent/ATE227572T1/de

Links

238000000605 extraction Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
239000003223 protective agent Substances 0.000 title 1
239000003963 antioxidant agent Substances 0.000 abstract 2
230000003078 antioxidant effect Effects 0.000 abstract 2
235000006708 antioxidants Nutrition 0.000 abstract 2
VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 abstract 1
HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 abstract 1
YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 abstract 1
230000000844 anti-bacterial effect Effects 0.000 abstract 1
230000001093 anti-cancer Effects 0.000 abstract 1
230000000843 anti-fungal effect Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000002141 anti-parasite Effects 0.000 abstract 1
229940121375 antifungal agent Drugs 0.000 abstract 1
239000002592 antimutagenic agent Substances 0.000 abstract 1
239000003096 antiparasitic agent Substances 0.000 abstract 1
JYTVKRNTTALBBZ-UHFFFAOYSA-N bis demethoxycurcumin Natural products C1=CC(O)=CC=C1C=CC(=O)CC(=O)C=CC1=CC=CC(O)=C1 JYTVKRNTTALBBZ-UHFFFAOYSA-N 0.000 abstract 1
PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 abstract 1
229940109262 curcumin Drugs 0.000 abstract 1
235000012754 curcumin Nutrition 0.000 abstract 1
239000004148 curcumin Substances 0.000 abstract 1
NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 abstract 1
YXAKCQIIROBKOP-UHFFFAOYSA-N di-p-hydroxycinnamoylmethane Natural products C=1C=C(O)C=CC=1C=CC(=O)C=C(O)C=CC1=CC=C(O)C=C1 YXAKCQIIROBKOP-UHFFFAOYSA-N 0.000 abstract 1
VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000007246 mechanism Effects 0.000 abstract 1
UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger

Landscapes

Health & Medical Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

AT96923703T 1995-07-14 1996-07-12 Lebenschützende mittel, verfahren zu deren verwendung sowie extraktionsverfahren für curcuminoide ATE227572T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US116195P	1995-07-14	1995-07-14
PCT/US1996/011431 WO1997003674A1 (en)	1995-07-14	1996-07-12	Bioprotectant composition, method of use and extraction process of curcuminoids

Publications (1)

Publication Number	Publication Date
ATE227572T1 true ATE227572T1 (de)	2002-11-15

Family

ID=21694687

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96923703T ATE227572T1 (de)	1995-07-14	1996-07-12	Lebenschützende mittel, verfahren zu deren verwendung sowie extraktionsverfahren für curcuminoide

Country Status (5)

Country	Link
EP (1)	EP0839037B1 (de)
AT (1)	ATE227572T1 (de)
AU (1)	AU6455596A (de)
DE (1)	DE69624818T2 (de)
WO (1)	WO1997003674A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9711962D0 (en) *	1997-06-10	1997-08-06	Reckitt & Colmann Prod Ltd	Therapeutically active compositions
GB9714564D0 (en) *	1997-07-10	1997-09-17	Zeneca Ltd	Composition
US6653327B2 (en)	1999-04-09	2003-11-25	Sabinsa Corporation	Cross-regulin composition of tumeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays
WO2000061162A1 (en) *	1999-04-09	2000-10-19	Sabinsa Corporation	Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa
US7728043B2 (en)	1999-10-22	2010-06-01	Kim Darrick S H L	Methods for treatment of beta-amyloid protein-induced ocular disease
US6887898B1 (en)	1999-10-22	2005-05-03	Darrick S. H. L. Kim	Pharmaceutical compositions useful in prevention and treatment of beta-Amyloid protein-induced disease
AU2300001A (en) *	1999-10-22	2001-05-08	Board Of Trustees Of The University Of Illinois, The	Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
US6576273B2 (en)	2000-08-24	2003-06-10	Chr. Hansen A/S	Purification process for improving total yield of curcuminoid colouring agent
ATE366780T1 (de) *	2000-08-24	2007-08-15	Hansens Lab	Reinigungsprozess zur verbesserung der gesamtausbeute curcuminoider farbmittel
US6979470B2 (en) *	2001-07-17	2005-12-27	Metaproteomics, Llc	Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
KR20030066927A (ko) *	2002-02-06	2003-08-14	구자영	쿠르쿠민과 5-프루오로유라실로 이루어진 항암제 및 이항암제의 용도
FR2838644B1 (fr) *	2002-04-23	2005-12-30	Oreal	Utilisation de derives de la 1,7-bisphenyl heptane-3,5-dione comme actifs inhibant le developpement des odeurs corporelles dans les compositions cosmetiques
AU2003270283A1 (en) *	2002-10-01	2004-04-23	Dr. Andre Rieks - Labor Fur Enzymtechnologie Gmbh	Novel curcumin/tetrahydrocurcumin derivatives for using in cosmetics, pharmaceuticals and for nutrition
EP1933625B1 (de)	2005-10-13	2014-07-09	Laila Nutraceuticals	Verfahren zur herstellung von angereicherten tetrahydroxycurcuminfraktionen sowie tetrahydrotetrahydroxycurcumin aus extrakten von curcuma longa
WO2009066303A2 (en)	2007-11-22	2009-05-28	Ganga Raju Gokaraju	New synergistic phytochemical composition for the treatment of obesity
US7785638B2 (en) *	2008-02-28	2010-08-31	Himalaya Global Holdings, Ltd	Herbal acne control composition, method of manufacturing the same and use thereof
WO2018020302A1 (en) *	2016-07-29	2018-02-01	Synthite Industries Limited	A process for extraction and isolation of curcuminoids
WO2018161145A1 (en)	2017-03-10	2018-09-13	Cavaleri Franco	Curcumin-based compositions & methods of use thereof
CZ307916B6 (cs)	2017-05-08	2019-08-21	mcePharma s. r. o.	Orodispergovatelná tableta s biodostupným kurkuminem a její použití
WO2020194344A1 (en) *	2019-03-24	2020-10-01	Patel Naishadhkumar Ramubhai	Formulation to enhance the bioavailibity and stability of curcuminoids and/or its derivatives thereof
CA3213258A1 (en) *	2021-04-30	2022-11-03	Muhammed Majeed	Compositions for management of polycystic ovary syndrome

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2239478A1 (en) *	1973-07-31	1975-02-28	Dufour Michel	Ethereal fruit oil and oleoresin extn. - from food-plant using water-soluble solvents pref. methylal
CH609215A5 (de) *	1976-03-09	1979-02-28	Nestle Sa
DE2924345A1 (de) *	1979-06-15	1981-01-08	Nattermann A & Cie	Verfahren zur herstellung eines curcumatrockenextraktes aus rhizoma curcumae longae bzw. rhizoma curcumae xanthorrhizae und gewinnung des aetherischen curcumaoels
US4263333A (en) *	1979-09-12	1981-04-21	General Foods Corporation	Curcumin-metal color complexes
US4719111A (en) *	1985-06-14	1988-01-12	Wilson Lynn M	Novel composition for treatment of decubitus ulcers
CA1297718C (en) *	1985-12-20	1992-03-24	Paul H. Todd, Jr.	Herb flavoring and/or antioxidant composition and process
US5108750A (en) *	1986-09-08	1992-04-28	Yaguang Liu	Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation
JPH0249747A (ja) *	1988-08-12	1990-02-20	Kobe Steel Ltd	抗酸化剤
KR920004818B1 (ko) *	1989-11-28	1992-06-18	태평양화학 주식회사	세포 보호제 조성물
US5120538A (en) *	1990-02-05	1992-06-09	Pt Darya-Varia Laboratoria	Combinations of compounds isolated from curcuma spp as anti-inflammatory agents
DE4137540A1 (de) *	1991-11-14	1993-05-19	Steigerwald Arzneimittelwerk	Verwendung von praeparaten der curcuma-pflanzen
WO1994013743A1 (en) *	1992-12-17	1994-06-23	Novo Nordisk A/S	Method for isolation of vegetable oleoresins producible by hexane extraction
ATE163838T1 (de) *	1993-08-17	1998-03-15	Nestle Sa	Verfahren zum extrahieren von pflanzlicher antioxidanten in flüssiger form
US5401504B1 (en) *	1993-12-28	1998-04-21	Univ Mississippi Medical Cente	Use of tumeric in wound healing
WO1996003999A1 (es) *	1994-08-03	1996-02-15	A.S.A.C. Pharmaceutical International, A.I.E.	Procedimiento para la obtencion de extractos apolares y polares de curcuma y aplicaciones de los mismos

1996
- 1996-07-12 AT AT96923703T patent/ATE227572T1/de not_active IP Right Cessation
- 1996-07-12 AU AU64555/96A patent/AU6455596A/en not_active Abandoned
- 1996-07-12 DE DE69624818T patent/DE69624818T2/de not_active Expired - Lifetime
- 1996-07-12 EP EP96923703A patent/EP0839037B1/de not_active Expired - Lifetime
- 1996-07-12 WO PCT/US1996/011431 patent/WO1997003674A1/en not_active Ceased

Also Published As

Publication number	Publication date
EP0839037B1 (de)	2002-11-13
EP0839037A4 (de)	1999-03-03
WO1997003674A1 (en)	1997-02-06
DE69624818T2 (de)	2003-04-10
EP0839037A1 (de)	1998-05-06
AU6455596A (en)	1997-02-18
DE69624818D1 (de)	2002-12-19

Legal Events

Date	Code	Title	Description
2003-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69624818D1 (de)	2002-12-19	Lebenschützende mittel, verfahren zu deren verwendung sowie extraktionsverfahren für curcuminoide
ES2106508T3 (es)	1997-11-01	Composiciones cosmeticas que contienen pigmentos tratados en la superficie.
DE69826443D1 (de)	2004-10-28	Antioxidative zusammensetzung
EP0832846A3 (de)	1998-07-08	Polymer-Wasserstoffperoxid-komplexe
CO4700531A1 (es)	1998-12-29	Compuestos y composiciones que comprenden un derivado de fosfato y un vehiculo que proveen una sensacion de calenta- miento
FR2758139B1 (fr)	2001-04-20	Compose photo-initiateur, compositions le contenant et leurs utilisations
DK0608322T3 (da)	1998-12-14	Forbedret hudpenetreringssystem til forbedret topisk frembringelse af lægemidler
BR0011042A (pt)	2002-06-04	Gel de silicone contendo ácido salicìlico
RU95108859A (ru)	1997-06-10	Косметическая композиция для топического применения и способ защиты кожи и/или волос
CA2162330A1 (fr)	1996-05-09	Nouveaux filtres solaires, compositions cosmetiques photoprotectrices les contenant et utilisations
DE69737297D1 (de)	2007-03-15	Verfahren, zusammensetzungen, sowie dentale verabreichungssysteme zum schutz von zahnoberflächen
DE59909764D1 (de)	2004-07-22	Mucoadhäsive polymere, deren verwendung sowie deren herstellungsverfahren
EP0898955A3 (de)	2001-11-21	Sonnenschutzmittel mit Ultraspektralschutz
MX9700275A (es)	1997-05-31	Composiciones cosmeticas para la fotoproteccion de la piel y/o de los cabellos a base de una mezcla sinergica de filtros y usos de las mismas.
DE69429806D1 (de)	2002-03-21	Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung
DE59704654D1 (de)	2001-10-25	Verwendung eines Extraktes aus Cimicifuga racemosa
EP0213099A3 (de)	1989-07-19	Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
WO2001030335A3 (en)	2002-06-13	Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
AR012546A1 (es)	2000-11-08	Utilizacion de al menos un compuesto seleccionado entre el grupo que comprende los sogaoles y los gingeroles para la preparacion de una composiciondesodorante, sogaol, extracto bruto y extracto purificado que contiene el sogaol y la composicion desodorante obtenida.
ATE52000T1 (de)	1990-05-15	Viruzides mittel.
AR008506A1 (es)	2000-01-19	Composicion farmaceutica.
DE69415026D1 (de)	1999-01-14	Ribosom-inaktievirende proteine, die aus saponaria ocymoides und vaccaria pyramidata samen extrahiert sind sowie deren herstellung und immunotoxine, die sie enthalten
DE59908525D1 (de)	2004-03-18	Trockenextrakt aus der hennapflanze, verfahren zu dessen herstellung und dessen verwendung
FR2716374B1 (fr)	1996-04-19	Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des extraits de plantes.
PT920336E (pt)	2004-06-30	Pesticidas que compreendem alcaloides da benzofenantridina